Article
Silencing tau to treat early Alzheimer's disease - Nature Medicine
Rating:
0.0
Views:
67
Likes:
1
Library:
1
An antisense oligonucleotide therapy substantially reduced tau expression in a phase 1b trial; whether this translates to clinical improvement remains to be seen, but it could have far-reaching implications for neurodegenerative diseases more broadly.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value